> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # COVID-19 Joint Biomanufacturing Subcommittee - URL: https://www.whiteroseintelligence.com/covid-19-joint-biomanufacturing-subcommittee/ - Published: 1999-01-02T14:28:00.000Z - Updated: 2026-02-20T03:43:58.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #organization, COVID-19, Organization The **COVID-19 Joint Biomanufacturing Subcommittee** was a Canadian government advisory group serving as a subcommittee of the [COVID-19 Vaccine Task Force](https://www.whiteroseintelligence.com/COVID-19-Vaccine-Task-Force), sharing its membership with the [COVID-19 Therapeutics Task Force](https://www.whiteroseintelligence.com/COVID-19-Therapeutics-Task-Force). It was "mandated to make recommendations to the government on various issues relating to the procurement and production of vaccines, including the development of a strategy to boost the country’s biomanufacturing capacity."[\[1\]](#fn1) It met 22 times between June 2020 and February 2021, for "a combined total of about 55 hours."[\[2\]](#fn2) ## History The first meeting of the subcommittee was on June 23, 2020.[\[1:1\]](#fn1) ### Meetings | Date | Proposal | Company | | ----------------- | -------------------------------------- | ------------------------------------------------------------------------------------ | | June 23, 2020 | Fill and Finish and Bill of Materials | \- | | June 25, 2020 | National Research Council - Royalmount | Biologics Manufacturing Centre | | June 29, 2020 | \- | Sanofi | | July 6, 2020 | National Research Council - Royalmount | Biologics Manufacturing Centre | | July 6, 2020 | Biomanufacturing project | [Precision NanoSystems](https://www.whiteroseintelligence.com/Precision-NanoSystems) | | July 6, 2020 | \- | KABS Laboratories, Novocol Pharma | | July 10, 2020 | Biomanufacturing project (follow-up) | [Precision NanoSystems](https://www.whiteroseintelligence.com/Precision-NanoSystems) | | July 14, 2020 | Follow-up | KABS Laboratories, Novocol Pharma | | September 4, 2020 | Follow-up | Sanofi | | January 21, 2021 | \- | Resilience Biotechnologies | ## Personnel Members of the subcommittee are listed on the [Government of Canada](https://www.whiteroseintelligence.com/Government-of-Canada)'s website, along with disclosures of interests.[\[3\]](#fn3) | Name | Position | Notes | | --------------------- | ----------------------- | ------------------------------------------------------------------------------------------------ | | Mark Lievonen | Co-chair[\[2:1\]](#fn2) | [COVID-19 Vaccine Task Force](https://www.whiteroseintelligence.com/COVID-19-Vaccine-Task-Force) | | Alan Bernstein | Member | \- | | Cédric Bisson | Member | \- | | Robert Brunham | Member | Applied for a grant from the Strategic Innovation Fund (SIF) | | Michel de Wilde | Member | Sanofi Pasteur | | Nancy Harrison | Member | Life Sciences British Columbia | | Joanne Langley | Member | Dalhousie University, Sanofi | | Christopher Procyshyn | Member | Vanrx Pharmasystems | | Benjamin Rovinski | Member | Sanofi | | Youla Tsantrizos | Member | \- | | Lorne Tyrrell | Member | \- | | Sylvia van den Hurk | Member | Sanofi | | André Veillette | Member | \- | --- 1. Lightbound, J. (2023). *Domestic Manufacturing Capacity for a COVID-19 Vaccine - Prevention is Better than Cure: Report of the Standing Committee on Industry and Technology* (pp. 17–18). House of Commons of Canada. [↩︎](#fnref1) [↩︎](#fnref1:1) 2. Lievonen, M. (2021, February 18). *Evidence - INDU (43-2) - No. 18.* House of Commons of Canada. [↩︎](#fnref2) [↩︎](#fnref2:1) 3. Innovation, Science and Economic Development Canada. (2022, July 7). *COVID-19 Joint Biomanufacturing Subcommittee*. Government of Canada. [↩︎](#fnref3)